Alert detail

LCD L36906: GlycoMark® Testing for Glycemic Control — CGS

Policy ID: LCD-L36906Specialty: EndocrinologyAdded: 6/5/2026Effective: April 2, 2026lcd
Routine

What changed

New GlycoMark® Testing effective April 2026.

Who’s affected: Endocrinology billing teams · Effective: April 2, 2026

Affected codes

Primary source: View the official CMS/MAC document ↗

Get the action steps and full analysis

This change affects 5 billing codes.

Subscribers get the recommended action (“what to do”), the full AI analysis, the LCD revision comparison, and related alerts across your specialty and jurisdiction.

Audit documentation

Building an audit file?

The Tripwire Audit Pack exports 12 months of Endocrinology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the Endocrinology audit pack — $349One-time purchase · not a subscription

Not ready to subscribe?

Get the free weekly reimbursement brief for Endocrinology— the week’s changes and deadlines, delivered to your inbox. No account required.